Image quality derived from echo liver imaging at 3T (A, left) improves (A, right) when applying Philips MultiTransmit technology, which eliminatesdielectric shading, an artifact commonly found at this field strength.
Image quality derived from echo liver imaging at 3T (A) improves when applying Philips MultiTransmit technology, which eliminates dielectric shading, an artifact commonly found at this field strength. Unveiled at RSNA 2008, MultiTransmit technology automatically adjusts multiple radiofrequency signals to accommodate the anatomy of specific patients, thereby improving image uniformity and increasing overall image consistency, according to the company. The technology, which is unique to the company’s Achieva 3.0T TX, is particularly helpful in patients with liver cirrhosis and ascites (B). These ascites can be challenging to image due to shielding effects of fluids (B, inset). MultiTransmit solves the problem, decreasing B1 inhomogeneity and, thereby, improving lesion visualization. The first installations of the Achieva 3.0T TX with MultiTransmit began operating earlier this year at Tokai University in Tokyo, Bonn University in Germany, and Fletcher Allen Health Care in Burlington, VT. Users are focusing on breast, spine, and abdominal imaging. (Provided by University of Bonn)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.